In fact, although numerous experimental models exist for both PD and melanoma, including those overexpressing or harboring mutant forms of SNCA/α-syn, they rarely capture the shared environmental, cellular, and immune components that underpin their comorbidity. This evidence concerns the gene SNCA and Parkinson disease.